Document is current
Any future updates will be listed below
-
Authors
Bigot, Jeanne
Legendre, Rachel https://orcid.org/0000-0002-5196-9431
Hamroune, Juliette
Jacques, Sébastien
Le Gars, Mathieu
Millet, Nicolas
Guillot, Loïc https://orcid.org/0000-0001-6853-7945
Corvol, Harriet https://orcid.org/0000-0002-7026-7523
Hennequin, Christophe
Guitard, Juliette
Coppée, Jean-Yves
Balloy, Viviane
Chica, Claudia https://orcid.org/0000-0002-3758-640X
-
Funding
Funding for this research was provided by:
Association Vaincre la Mucoviscidose (RF20200502697)
Air Liquide (R20087DD/RAK20016DDA)
- License Information
-
More Information
Article History
Received: 16 October 2024
Revised: 18 July 2025
Accepted: 1 September 2025
First Online: 24 September 2025
Competing interests
: The authors declare no competing interests.
: Ethics approval was not required for this study as all experiments were conducted using the commercially available BEAS-2B cell line (American Type Culture Collection, Rockville, MD, USA), which is an established immortalized human bronchial epithelial cell line. No primary human tissues, human subjects, or animal models were involved in this research. All cell culture and experimental procedures were performed in accordance with standard laboratory guidelines, institutional biosafety regulations, and manufacturer’s recommendations.
: Not applicable—this study does not involve human participants and contains no individual participant data.
